Neos Therapeutics, Inc. 4
4 · Neos Therapeutics, Inc. · Filed Sep 3, 2015
Insider Transaction Report
Form 4
McDonnell Thomas P
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2015-09-01+43,586→ 43,586 totalExercise: $25.50Exp: 2025-09-01→ Common Stock (43,586 underlying)
Footnotes (1)
- [F1]This stock option vests in equal yearly installments over a four-year period which began on September 1, 2015.